Department of Anaesthesia, Glasgow Royal Infirmary, Glasgow, UK
School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
BMJ. 2024 May 22;385:e077190. doi: 10.1136/bmj-2023-077190.
To determine the effect of labour epidural on severe maternal morbidity (SMM) and to explore whether this effect might be greater in women with a medical indication for epidural analgesia during labour, or with preterm labour.
Population based study.
All NHS hospitals in Scotland.
567 216 women in labour at 24+0 to 42+6 weeks' gestation between 1 January 2007 and 31 December 2019, delivering vaginally or through unplanned caesarean section.
The primary outcome was SMM, defined as the presence of ≥1 of 21 conditions used by the US Centers for Disease Control and Prevention (CDC) as criteria for SMM, or a critical care admission, with either occurring at any point from date of delivery to 42 days post partum (described as SMM). Secondary outcomes included a composite of ≥1 of the 21 CDC conditions and critical care admission (SMM plus critical care admission), and respiratory morbidity.
Of the 567 216 women, 125 024 (22.0%) had epidural analgesia during labour. SMM occurred in 2412 women (4.3 per 1000 births, 95% confidence interval (CI) 4.1 to 4.4). Epidural analgesia was associated with a reduction in SMM (adjusted relative risk 0.65, 95% CI 0.50 to 0.85), SMM plus critical care admission (0.46, 0.29 to 0.73), and respiratory morbidity (0.42, 0.16 to 1.15), although the last of these was underpowered and had wide confidence intervals. Greater risk reductions in SMM were detected among women with a medical indication for epidural analgesia (0.50, 0.34 to 0.72) compared with those with no such indication (0.67, 0.43 to 1.03; P<0.001 for difference). More marked reductions in SMM were seen in women delivering preterm (0.53, 0.37 to 0.76) compared with those delivering at term or post term (1.09, 0.98 to 1.21; P<0.001 for difference). The observed reduced risk of SMM with epidural analgesia was increasingly noticeable as gestational age at birth decreased in the whole cohort, and in women with a medical indication for epidural analgesia.
Epidural analgesia during labour was associated with a 35% reduction in SMM, and showed a more pronounced effect in women with medical indications for epidural analgesia and with preterm births. Expanding access to epidural analgesia for all women during labour, and particularly for those at greatest risk, could improve maternal health.
确定分娩时使用硬膜外麻醉对严重产妇发病率(SMM)的影响,并探讨在有分娩时硬膜外镇痛医学指征的妇女或有早产的妇女中,这种影响是否更大。
基于人群的研究。
苏格兰所有国民保健服务(NHS)医院。
2007 年 1 月 1 日至 2019 年 12 月 31 日期间,24+0 至 42+6 周妊娠期间阴道分娩或计划外剖宫产的 567216 名妇女。
主要结局是 SMM,定义为美国疾病控制与预防中心(CDC)使用的 21 种疾病中的≥1种(CDC 将这些疾病作为 SMM 的标准)或重症监护病房(NICU)入院,且这两种情况在分娩后任何时间至产后 42 天都可能发生(称为 SMM)。次要结局包括 21 种 CDC 疾病和 NICU 入院的复合结局(SMM 加 NICU 入院)和呼吸发病率。
在 567216 名妇女中,125024 名(22.0%)在分娩时使用了硬膜外镇痛。有 2412 名妇女发生 SMM(每 1000 例分娩中有 4.3 例,95%置信区间(CI)为 4.1 至 4.4)。硬膜外镇痛与 SMM 减少相关(调整后的相对风险 0.65,95%CI 0.50 至 0.85),SMM 加 NICU 入院(0.46,0.29 至 0.73)和呼吸发病率(0.42,0.16 至 1.15),尽管后一种情况的效力不足且置信区间较宽。在有硬膜外镇痛医学指征的妇女中,SMM 的风险降低更为显著(0.50,0.34 至 0.72),而在无此类指征的妇女中,SMM 的风险降低(0.67,0.43 至 1.03;P<0.001)。与足月或过期分娩的妇女相比,早产(0.53,0.37 至 0.76)的 SMM 降低更为显著(P<0.001)。在整个队列中,以及在有硬膜外镇痛医学指征的妇女中,随着出生时的胎龄下降,观察到的 SMM 风险降低与硬膜外镇痛的相关性越来越明显。
分娩时使用硬膜外镇痛与 SMM 降低 35%相关,并且在有硬膜外镇痛医学指征的妇女和早产妇女中具有更显著的效果。为所有分娩妇女,特别是风险最高的妇女扩大硬膜外镇痛的使用,可能会改善产妇的健康状况。